Evaluating Quality Adjusted Life in Acute Ischemic Stroke Patients: Insights from Door-to-Needle Time Observations
1, 1, 1, 1, 2, 3, 1, 1, 1
- 1Department of Pharmacy Practice, Nandha College of Pharmacy, Erode, Tamil Nadu, INDIA.
- 2Clinical Pharmacist, NG Hospital and Research Centre, Coimbatore, Tamil Nadu, INDIA.
- 3Consultant Neurologist, NG Hospital and Research Centre, Coimbatore, Tamil Nadu, INDIA.
CORRESPONDENCE
Mr. Balaprasath Balaji
Pharm D, Department of Pharmacy Practice, Nandha College of Pharmacy, Erode-638052, Tamil Nadu, PHILIPPINES.
Received: 16-09-2024; Revised: 06-12-2024; Accepted: 24-03-2025.
Volume 14, Issue 1 · pp. 173-176 · 2025 · DOI: 10.5530/ajbls.20251362
ABSTRACT
Aim/Background: To assess the safety and effectiveness of tenecteplase in acute ischemic stroke patients treated within 3.5 hr of symptom on set, evaluating its potential as a cost-effective treatment option.Materials and Methods: Study population: 38 patients over 35 years old, Demographics: Predominantly male (62.5%), age range 56-65 years, Lifestyle analysis: 58.3% smokers, 44.7% alcohol consumers, Treatment: Tenecteplase administered within 3.5 hr of symptom onset.Results: Patient Outcomes: 94.73% achieved independence in daily activities; 56.25% experienced shorter hospital stays (3-5 days); 81.05% positive outcomes at discharge; 94.21% improvement after one month; Quality-Adjusted Life Year (QALY) analysis showed significant improvement; Demonstrated cost-effectiveness compared to other thrombolytic treatments.Conclusion: Tenecteplase emerges as a safe and cost-effective treatment for Acute Ischemic Stroke, demonstrating significant improvements in neurological recovery, patient independence, and potential reduction in healthcare costs while enhancing patient quality of life.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Balaji, B., Sivakumar, A., Benny, A., Ramalingam, B., Pandian, D. V., Shivaraman, A., Singaravel, S., Sherief, S. H., & D, D. (2025). Evaluating Quality Adjusted Life in Acute Ischemic Stroke Patients: Insights from Door-to-Needle Time Observations. Asian Journal of Biological and Life Sciences, 14(1), 173-176. https://doi.org/10.5530/ajbls.20251362
Copyright and licence
© 2025 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0
